OSUR

OraSure Technologies Inc

OSUR, USA

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic and specimen collection devices and products in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; and Colli-Pee collection devices for the volumetric collection of void urine samples. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, the company offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. The company sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.

https://www.orasure.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
OSUR
stock
OSUR

Stocks of Orasure Technologies Inc (OSUR) are poised to climb above their peers Setenews

Read more →
OSUR
stock
OSUR

OraSure Technologies, Inc. $OSUR Shares Sold by American Century Companies Inc. MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$4.5

Analyst Picks

Strong Buy

1

Buy

0

Hold

3

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.51

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-3.79 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-3.24 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-40.58 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.17

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 87.83% of the total shares of OraSure Technologies Inc

1.

BlackRock Inc

(8.9807%)

since

2025/06/30

2.

Private Management Group Inc

(7.4674%)

since

2025/06/30

3.

Vanguard Group Inc

(5.8143%)

since

2025/06/30

4.

Neuberger Berman Group LLC

(5.6838%)

since

2025/06/30

5.

Dimensional Fund Advisors, Inc.

(5.2464%)

since

2025/06/30

6.

Renaissance Technologies Corp

(3.1124%)

since

2025/06/30

7.

Systematic Financial Management LP

(3.0478%)

since

2025/06/30

8.

Altai Capital Management, L.P.

(2.9566%)

since

2025/06/30

9.

Vanguard Total Stock Mkt Idx Inv

(2.9457%)

since

2025/07/31

10.

American Century Companies Inc

(2.8461%)

since

2025/06/30

11.

Geode Capital Management, LLC

(2.5567%)

since

2025/06/30

12.

Cannell Capital LLC

(2.55%)

since

2025/06/30

13.

iShares Russell 2000 ETF

(2.4796%)

since

2025/08/31

14.

Bridgeway Capital Management, LLC

(2.4478%)

since

2025/06/30

15.

JPMorgan Chase & Co

(2.3475%)

since

2025/06/30

16.

D. E. Shaw & Co LP

(2.2632%)

since

2025/06/30

17.

Gagnon Securities LLC

(2.1933%)

since

2025/06/30

18.

State Street Corp

(2.1794%)

since

2025/06/30

19.

Steamboat Capital Partners, LLC

(2.1782%)

since

2025/06/30

20.

Millennium Management LLC

(1.6877%)

since

2025/06/30

21.

Gagnon Advisors, LLC

(1.6509%)

since

2025/06/30

22.

Neuberger Berman Intrinsic Value I

(1.5753%)

since

2025/07/31

23.

Jacobs Levy Equity Management, Inc.

(1.4512%)

since

2025/06/30

24.

DFA US Small Cap Value I

(1.1212%)

since

2025/07/31

25.

Vanguard Institutional Extnd Mkt Idx Tr

(1.1093%)

since

2025/07/31

26.

Fidelity Small Cap Index

(1.0306%)

since

2025/06/30

27.

iShares Russell 2000 Value ETF

(0.8917%)

since

2025/08/31

28.

DFA US Targeted Value I

(0.8654%)

since

2025/07/31

29.

Bridgeway Ultra-Small Company

(0.7371%)

since

2025/06/30

30.

Bridgeway Small-Cap Value

(0.7301%)

since

2025/06/30

31.

Bridgeway Small Cap Value

(0.7301%)

since

2025/06/30

32.

Dimensional US Targeted Value ETF

(0.6727%)

since

2025/08/29

33.

BlackRock Advantage Small Cap Core Instl

(0.6627%)

since

2025/07/31

34.

JPMorgan US Small Company L

(0.6609%)

since

2025/07/31

35.

Fidelity Extended Market Index

(0.5513%)

since

2025/07/31

36.

Neuberger Berman US SCp Intrs Val $I Acc

(0.5416%)

since

2025/05/31

37.

Vanguard Russell 2000 ETF

(0.4911%)

since

2025/07/31

38.

Schwab US Small-Cap ETFâ„¢

(0.4886%)

since

2025/08/30

39.

Multi-Manager Small Cap Eq Strat Inst

(0.4438%)

since

2025/07/31

40.

DFA US Small Cap I

(0.4411%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.165

Latest Release

Date

2025-09-30

EPS Actual

-0.13

EPS Estimate

-0.19

EPS Difference

0.06

Surprise Percent

31.5789%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(6.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1)
Momentum
Moderate Momentum(3.5)
Net Net
Possible Net-Net(6)
Quality
Low Quality Business(2.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.